Total Payments
$1,723
2024 Payments
$559.40
Companies
18
Transactions
72
Medicare Patients
627
Medicare Billing
$93,602
Payment Breakdown by Category
Food & Beverage$1,613 (93.6%)
Education$110.33 (6.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,613 | 63 | 93.6% |
| Education | $110.33 | 9 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $303.17 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $268.20 | 18 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $183.93 | 4 | $0 (2024) |
| Amgen Inc. | $149.29 | 2 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $124.26 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $111.45 | 6 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $104.73 | 5 | $0 (2024) |
| Vifor Pharma, Inc. | $104.54 | 4 | $0 (2023) |
| Travere Therapeutics, Inc. | $86.35 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $72.20 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $559.40 | 30 | Travere Therapeutics, Inc. ($86.35) |
| 2023 | $543.46 | 20 | Mallinckrodt Hospital Products Inc. ($125.00) |
| 2022 | $620.29 | 22 | Otsuka America Pharmaceutical, Inc. ($154.70) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Nephrology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $30.29 | General |
| 10/24/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Nephrology | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 10/07/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $11.77 | General |
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: DIABETES | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 08/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $11.77 | General |
| 08/13/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 08/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: NEPHROLOGY | ||||||
| 08/02/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Inflammation | ||||||
| 07/30/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 07/30/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $11.77 | General |
| 07/17/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Genetic Disease | ||||||
| 07/02/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: CRITICAL CARE | ||||||
| 06/18/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardiology | ||||||
| 06/10/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Nephrology | ||||||
| 05/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Cardio-renal | ||||||
| 04/11/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Nephrology | ||||||
| 04/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardio-renal | ||||||
| 03/28/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: NEPHROLOGY | ||||||
| 03/20/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 530 | 952 | $280,404 | $78,705 |
| 2022 | 3 | 97 | 208 | $52,202 | $14,897 |
Total Patients
627
Total Services
1,160
Medicare Billing
$93,602
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 148 | 385 | $84,209 | $23,968 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 145 | $49,999 | $14,329 | 28.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 68 | $36,715 | $9,465 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $26,089 | $7,066 | 27.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 49 | 51 | $19,391 | $5,324 | 27.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 51 | $15,984 | $4,804 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 33 | $15,312 | $4,748 | 31.0% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 27 | 60 | $12,498 | $3,441 | 27.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 69 | $10,350 | $2,682 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $7,216 | $2,173 | 30.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 11 | 22 | $2,640 | $705.98 | 26.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 157 | $32,188 | $9,035 | 28.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 38 | $14,279 | $4,156 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $5,736 | $1,706 | 29.7% |
About Dr. Deep Phachu, M.D
Dr. Deep Phachu, M.D is a Nephrology healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2017. The National Provider Identifier (NPI) number assigned to this provider is 1912435736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deep Phachu, M.D has received a total of $1,723 in payments from pharmaceutical and medical device companies, with $559.40 received in 2024. These payments were reported across 72 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,613).
As a Medicare-enrolled provider, Phachu has provided services to 627 Medicare beneficiaries, totaling 1,160 services with total Medicare billing of $93,602. Data is available for 2 years (2022–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Worcester, MA
- Active Since 05/24/2017
- Last Updated 02/03/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1912435736
Products in Payments
- JYNARQUE (Drug) $303.17
- BENLYSTA (Biological) $250.41
- TERLIVAZ (Drug) $183.93
- Repatha (Biological) $124.91
- Auryxia (Drug) $124.26
- Kerendia (Drug) $111.45
- TARPEYO (Drug) $104.73
- Veltassa (Drug) $104.54
- LOKELMA (Drug) $72.20
- Renal - HD (Device) $70.58
- TAVNEOS (Drug) $24.38
- JARDIANCE (Drug) $24.02
- ULTOMIRIS (Biological) $20.49
- FUROSCIX (Drug) $20.33
- LUPKYNIS (Drug) $19.69
- JESDUVROQ (Drug) $17.79
- FABRAZYME (Biological) $16.75
- KRYSTEXXA (Biological) $12.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Worcester
Anil Chandraker, Mbchb, MBCHB
Nephrology — Payments: $113,459
Nephrology $113,459
Matthew Trainor, M.d, M.D
Nephrology — Payments: $26,309
Nephrology $26,309
Maria Delrosario, M.d, M.D
Nephrology — Payments: $4,775
Nephrology $4,775
Xavier Vela Parada, Md, MD
Nephrology — Payments: $2,457
Nephrology $2,457
Dr. Neeraj Jain, M.d, M.D
Nephrology — Payments: $1,270
Nephrology $1,270
Nishanth Girija Kumar, M.d, M.D
Nephrology — Payments: $1,040
Nephrology $1,040